|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/16 | |
| A61K 47/10 | |||
| A61K 47/34 | |||
| A61K 31/5575 | |||
| A61K 31/165 |
| (11) | Patento numeris | 3351239 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17204626.0 |
| Europos patento paraiškos padavimo data | 2014-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361898241 P | 2013-10-31 | US |
| (72) |
Ghebremeskel, Alazar N., US
Robinson, Michael R., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF |
| PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF |